Margaret E. Torrence

2.1k total citations · 1 hit paper
13 papers, 1.0k citations indexed

About

Margaret E. Torrence is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Margaret E. Torrence has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Margaret E. Torrence's work include Cancer, Hypoxia, and Metabolism (4 papers), Tuberous Sclerosis Complex Research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Margaret E. Torrence is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Tuberous Sclerosis Complex Research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Margaret E. Torrence collaborates with scholars based in United States, Switzerland and France. Margaret E. Torrence's co-authors include Aaron M. Hosios, Brendan D. Manning, Matthew G. Vander Heiden, Jared R. Mayers, John M. Asara, Elizaveta Freinkman, Dennis Vitkup, Brian M. Wolpin, Alexander Muir and Laura V. Danai and has published in prestigious journals such as Science, Nature Communications and Scientific Reports.

In The Last Decade

Margaret E. Torrence

12 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue of origin dictates branched-chain amino acid metabolism in mutantKras-driven cancers

2016 438 citations Jared R. Mayers, Margaret E. Torrence et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margaret E. Torrence United States	8	714	509	286	110	108	13	1.0k
Robert F. Shearer Australia	15	925 1.3×	406 0.8×	393 1.4×	97 0.9×	159 1.5×	18	1.3k
Samuel K. McBrayer United States	18	778 1.1×	484 1.0×	196 0.7×	49 0.4×	40 0.4×	44	1.2k
Chiara Balestrieri Italy	11	738 1.0×	496 1.0×	253 0.9×	41 0.4×	61 0.6×	19	1.1k
Samah El Ghamrasni Canada	12	523 0.7×	274 0.5×	208 0.7×	56 0.5×	89 0.8×	16	752
Cristovão M. Sousa United States	4	683 1.0×	605 1.2×	468 1.6×	58 0.5×	63 0.6×	4	1.2k
Martin F. Orth Germany	11	664 0.9×	478 0.9×	193 0.7×	34 0.3×	43 0.4×	13	940
Mita Mukherjee United States	7	971 1.4×	690 1.4×	226 0.8×	46 0.4×	43 0.4×	10	1.2k
Reiko Satow Japan	20	780 1.1×	218 0.4×	199 0.7×	52 0.5×	190 1.8×	32	1.1k
Francisco Mansilla Denmark	20	809 1.1×	276 0.5×	291 1.0×	46 0.4×	146 1.4×	36	1.2k
Xiaodong Liao China	12	902 1.3×	303 0.6×	442 1.5×	49 0.4×	155 1.4×	22	1.2k

Countries citing papers authored by Margaret E. Torrence

Since Specialization

Citations

This map shows the geographic impact of Margaret E. Torrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret E. Torrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret E. Torrence more than expected).

Fields of papers citing papers by Margaret E. Torrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret E. Torrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret E. Torrence. The network helps show where Margaret E. Torrence may publish in the future.

Co-authorship network of co-authors of Margaret E. Torrence

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret E. Torrence. A scholar is included among the top collaborators of Margaret E. Torrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret E. Torrence. Margaret E. Torrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Yuskaitis, Christopher J., Michael R. MacArthur, Sarah J. Mitchell, et al.. (2022). The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth. Cell Reports. 39(7). 110824–110824. 8 indexed citations

Hosios, Aaron M., Margaret E. Torrence, Ting C. Zhao, et al.. (2022). Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex. iScience. 25(11). 105458–105458. 3 indexed citations

Hosios, Aaron M., et al.. (2022). mTORC1 regulates a lysosome-dependent adaptive shift in intracellular lipid species. Nature Metabolism. 4(12). 1792–1811. 29 indexed citations

Torrence, Margaret E., Michael R. MacArthur, Aaron M. Hosios, et al.. (2021). The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals. eLife. 10. 148 indexed citations

Valvezan, Alexander J., et al.. (2020). IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex. JCI Insight. 5(7). 25 indexed citations

Mitchell, Sarah J., Michael R. MacArthur, Alice E. Kane, et al.. (2020). Late-Onset Pharmacological or Dietary Interventions Improve Healthspan and Lifespan in Male and Female Mice. Innovation in Aging. 4(Supplement_1). 125–125. 2 indexed citations

Mitchell, Sarah J., Michael R. MacArthur, Alice E. Kane, et al.. (2019). IMPROVED HEALTHSPAN AND LIFESPAN WITH LATE ONSET PHARMACOLOGICAL OR DIETARY INTERVENTIONS IN MICE. Innovation in Aging. 3(Supplement_1). S875–S875. 1 indexed citations

Zbinden, Marie, et al.. (2017). mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci. Scientific Reports. 7(1). 16112–16112. 6 indexed citations

Olivares, O. Porta, Jared R. Mayers, Victoire Gouirand, et al.. (2017). Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nature Communications. 8(1). 16031–16031. 309 indexed citations

10.

Torrence, Margaret E. & Brendan D. Manning. (2017). Nutrient Sensing in Cancer. 2(1). 251–269. 36 indexed citations

11.

Mayers, Jared R., Margaret E. Torrence, Laura V. Danai, et al.. (2016). Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers. PMC. 34 indexed citations

12.

Mayers, Jared R., Margaret E. Torrence, Laura V. Danai, et al.. (2016). Tissue of origin dictates branched-chain amino acid metabolism in mutantKras-driven cancers. Science. 353(6304). 1161–1165. 438 indexed citations breakdown →

13.

Mayers, Jared R., Margaret E. Torrence, Brian P. Fiske, et al.. (2014). Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development. DSpace@MIT (Massachusetts Institute of Technology).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact